UPDATED: Clinician FAQS and guidance on COVID-19 vaccine

The Clinician FAQS and guidance on COVID-19 vaccine for patient receiving SACT. Version 6.0. Updated 21st December 2021 is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications. 

This updated guidance version 6 changes:
•    FAQ 1 Clarification for hormonal agents
•    FAQ 8 updated to reflect reinforcing (booster) dose after 3 primary doses.
•    FAQ13a: Updated figure
•    FAQ 13 FAQ 13b Updated to reflect change in recommendation about optimal timing.
•    New FAQ 14 added to reflect need for a reinforcing (booster) dose after 3rd primary dose

Please share with your colleagues.

Have a Merry Christmas and Happy New Year

Netty Cracknell and Pinkie Chambers
Co-chairs of the UK Chemotherapy Board

Latest News

By BOPA E&T Subcommittee on 15th January 2026

BOPA Introduction to Cancer Course, Scotland, March 2026 – LIMITED spaces available don’t miss out!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA E&T Subcommittee on 13th January 2026

Cancer Advanced and Consultant Pharmacist credentialing support series

As we head into 2026, BOPA is really pleased to share that the credentialing webinar support series from BOPA will continue in 2026. Through ongoing membership feedback, we’ve clearly identified…

Read article
By BOPA Research Committee on 26th December 2025

Optimising Medication in Older Adults Receiving Systemic Anticancer Therapies (SACT) – Research Study

We are inviting pharmacy professionals working in UK cancer services to take part in our study. What this research is about? To explore how pharmacy teams optimise medication for older…

Read article
By Caoimhe Keenan on 18th December 2025

Closing the Gap: Bridging Oral Mucositis Guidelines and Clinical Reality

Welcome to our lunchtime online event where we’ll delve into the clinical reality of oral mucositis. Join us as we explore new approaches to care for this common side effect…

Read article